Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
FENC
FENC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
FENC News
B. Riley Begins Coverage of Fennec Pharmaceuticals Inc. with a Buy Rating and $16 Price Target
4d ago
moomoo
Southpoint Disposes 1M Shares of Fennec Pharmaceuticals, Now Holds 8% Stake
Dec 26 2025
Globenewswire
Southpoint Disposes 1M Shares of Fennec Pharmaceuticals, Now Holds 8% Stake
Dec 26 2025
Newsfilter
Southpoint Disposes 1M Shares of Fennec Pharmaceuticals, Now Holds 8% Stake
Dec 26 2025
Yahoo Finance
Fennec Pharmaceuticals Initiates Study of PEDMARK® to Reduce Ototoxicity in Adult Testicular Cancer Patients
Dec 09 2025
Newsfilter
Pedmark Shows Promising Results in Japan Study — Reduced Hearing Loss with Equivalent Cancer-Fighting Efficacy
Dec 02 2025
Benzinga
Fennec Pharmaceuticals' PEDMARK® Significantly Reduces Hearing Loss in Children
Dec 02 2025
Globenewswire
Fennec Pharmaceuticals' PEDMARK® Significantly Reduces Hearing Loss in Children
Dec 02 2025
Newsfilter
Fennec Pharmaceuticals to Participate in Piper Sandler Healthcare Conference on December 3, 2025
Nov 26 2025
Globenewswire
Fennec Pharmaceuticals Confirms Full Debt Redemption Completion
Nov 19 2025
Newsfilter
Fennec Pharmaceuticals Completes Private Placement of Common Shares in Canada
Nov 18 2025
Newsfilter
Fennec Pharmaceuticals Completes Common Shares Offering
Nov 17 2025
Yahoo Finance
Fennec Pharmaceuticals Unveils Private Sale of Common Shares in Canada
Nov 14 2025
Yahoo Finance
Fennec Pharmaceuticals Reveals Pricing for Common Shares Offering
Nov 14 2025
Yahoo Finance
Niagen Bioscience (NAGE) Exceeds Expectations for Q3 Earnings and Revenue
Nov 05 2025
NASDAQ.COM
HC Wainwright & Co. Affirms Buy Rating for Fennec Pharmaceuticals, Keeps $13 Price Target Intact
Aug 21 2025
Benzinga
Show More News
